Hispanic lung cancer patients tend to live longer than blacks and whites

April 23, 2012

A new analysis has found that Hispanic lung cancer patients seem to live longer than white or black patients. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the study suggests that, as with several other types of cancer, certain yet-to-be-defined genetic and/or environmental factors put Hispanic patients at a survival advantage.

Most studies that look at ethnic and in lung cancer compare black patients with whites. To see how Hispanics compare with other ethnicities with regards to survival after a lung cancer diagnosis, Ali Saeed, an MD/PhD candidate, and Brian Lally, MD, of the University of Miami Miller School of Medicine, led a team that analyzed patient information from the Survival, Epidemiology, and End Results (SEER) Database, which compiles incidence and survival data from population-based cancer registries in the United States.

The investigators identified 172,398 adult patients who were diagnosed with any stage of non-small cell lung cancer (the most common form of lung cancer) between 1988 and 2007.

Compared with white patients, had a 15 percent lower risk of dying during the years of the study, whether they were born in the United States or not. "This is important because it shows that our findings are indicative of the in general and not specific to specific groups of Hispanics," said Saeed. Black patients were slightly more likely to die than whites. Also, Hispanics were more likely to develop a lung called bronchioalveolar carcinoma that is not as serious or life-threatening as other types.

"Our findings will motivate researchers and physicians to understand why Hispanics have more favorable outcomes and may shed light on potential environmental factors and/or genetic factors that can explain our observations," said Saeed. "For instance, the fact that Hispanics developed higher frequencies of bronchioalveolar carcinoma could be due to genetic predispositions and/or their lower smoking rates." (Smokers are at increased risk for developing tumor types associated with a poor prognosis.)

Saeed noted that the results fit into a phenomenon known as the "Hispanic paradox," in which Hispanics tend to have more favorable outcomes after being diagnosed with certain diseases despite having socioeconomic factors (such as decreased access to health care and higher poverty rates) that would predict otherwise. This paradox is seen for breast cancer, prostate cancer, cardiovascular disease, and now non-small cell lung cancer.

Explore further: Death rate higher in minorities with acute leukemia

Related Stories

Death rate higher in minorities with acute leukemia

September 19, 2011
Blacks and Hispanics have fewer cases of acute leukemia compared to whites but they die at a substantially higher rate, according to study results presented at the Fourth AACR Conference on The Science of Cancer Health Disparities, ...

Recommended for you

'Bet hedging' explains the efficacy of many combination cancer therapies

December 14, 2017
The efficacy of many FDA-approved cancer drug combinations is not due to synergistic interactions between drugs, but rather to a form of "bet hedging," according to a new study published by Harvard Medical School researchers ...

Liquid biopsy results differed substantially between two providers

December 14, 2017
Two Johns Hopkins prostate cancer researchers found significant disparities when they submitted identical patient samples to two different commercial liquid biopsy providers. Liquid biopsy is a new and noninvasive alternative ...

Scientists unlock structure of mTOR, a key cancer cell signaling protein

December 14, 2017
Researchers in the Sloan Kettering Institute have solved the structure of an important signaling molecule in cancer cells. They used a new technology called cryo-EM to visualize the structure in three dimensions. The detailed ...

Testing the accuracy of FDA-approved and lab-developed cancer genetics tests

December 14, 2017
Cancer molecular testing can drive clinical decision making and help a clinician determine if a patient is a good candidate for a targeted therapeutic drug. Clinical tests for common cancer causing-mutations in the genes ...

Newest data links inflammation to chemo-brain

December 14, 2017
Inflammation in the blood plays a key role in "chemo-brain," according to a published pilot study that provides evidence for what scientists have long believed.

One in five young colon cancer patients have genetic link

December 13, 2017
As doctors grapple with increasing rates of colorectal cancers in young people, new research from the University of Michigan may offer some insight into how the disease developed and how to prevent further cancers. Researchers ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.